Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol
Azuara-Blanco, Augusto, Logan, Nicola, Strang, Niall, Saunders, Kathryn, Allen, Peter M, Weir, Ruth, Doherty, Paul, Adams, Catherine, Gardner, Evie, Hogg, Ruth, McFarland, Margaret, Preston, Jennifer, Verghis, Rejina, Loughman, James J, Flitcroft, Ian, Mackey, David A, Lee, Samantha Sze-Yee, Hammond, Christopher, Congdon, Nathan, Clarke, Mike
Published in British journal of ophthalmology (01.07.2020)
Published in British journal of ophthalmology (01.07.2020)
Get full text
Journal Article
Western Australia Atropine for the Treatment of Myopia (WA‐ATOM) study: Rationale, methodology and participant baseline characteristics
Lee, Samantha S.Y., Mackey, David A., Lingham, Gareth, Crewe, Julie M., Richards, Michael D., Chen, Fred K., Charng, Jason, Ng, Fletcher, Flitcroft, Ian, Loughman, James J., Azuara‐Blanco, Augusto, Logan, Nicola S., Hammond, Christopher J., Chia, Audrey, Truong, Tan Tai, Clark, Antony
Published in Clinical & experimental ophthalmology (01.07.2020)
Published in Clinical & experimental ophthalmology (01.07.2020)
Get full text
Journal Article